Provided by Tiger Trade Technology Pte. Ltd.

Cabot

79.20
-1.5600-1.93%
Volume:517.54K
Turnover:41.13M
Market Cap:4.09B
PE:22.26
High:80.51
Open:79.20
Low:78.37
Close:80.76
52wk High:94.53
52wk Low:58.33
Shares:51.62M
Float Shares:50.93M
Volume Ratio:1.48
T/O Rate:1.02%
Dividend:1.82
Dividend Rate:2.30%
EPS(TTM):3.56
EPS(LYR):6.02
ROE:13.35%
ROA:8.90%
PB:2.55
PE(LYR):13.16

Loading ...

Cabot Q2 adjusted EPS beats estimates

Reuters
·
May 06

Cabot Q2 Adj. EPS $1.61 Beats $1.46 Estimate, Sales $904.000M Beat $900.305M Estimate

Benzinga Earnings
·
May 06

BRIEF-Cabot Q2 Adjusted EPS USD 1.61 Vs. IBES Estimate USD 1.46

Reuters
·
May 06

Cabot: Outlook Reflects Expected Impact of Middle East Conflict

THOMSON REUTERS
·
May 06

Cabot Q2 Sales USD 904 Million VS. Ibes Estimate USD 900.3 Million

THOMSON REUTERS
·
May 06

Cabot: Cautious of Potential Changes in Demand Levels Towards the End of 2026 Due to Disruptions From Middle East Crisis

THOMSON REUTERS
·
May 06

Press Release: Cabot Corporation Reports Second Quarter Fiscal Year 2026 Results

Dow Jones
·
May 06

Cabot increases quarterly dividend 5% to 47.25c per share

TIPRANKS
·
May 05

Cabot Corp - Declares Qtrly Dividend of $0.4725 per Share, up 5%

THOMSON REUTERS
·
May 05

Press Release: Cabot Corporation Board Increases Dividend

Dow Jones
·
May 05

CLOUDBREAK-B Receives FDA Clearance for Safety Review of CBT-199

Stock News
·
Apr 30

Earning Preview: Cabot revenue expected to decrease by 12.10% this quarter, and institutional views are cautious

Earnings Agent
·
Apr 28

Cabot sets webcast and conference call for fiscal Q2 operating results

Reuters
·
Apr 09

BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions

GlobeNewswire
·
Apr 08

Centenario Gold Closes Final Financing Tranche After Cabot Project Approval

TIPRANKS
·
Mar 26

Assessing Cabot (CBT) Valuation After Recent Pullback And Discounted P/E Multiple

Simply Wall St.
·
Mar 20

CLOUDBREAK-B Shares Drop Over 6% to Record Low Following Withdrawal of CBT-009 Clinical Trial Application

Stock News
·
Mar 20